186 results on '"Tuddenham, Edward G. D."'
Search Results
2. Application of PCR to the Detection and Analysis of Point Mutations in the Human Factor VIII Gene
3. Long-Term Persistence of Antibodies to Adeno-Associated Viral Vectors Following Gene Therapy with scAAV8-LP1-Fixco
4. Haemophilia, the journey in search of a cure. 1960–2020
5. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
6. Human Congenital Diseases with Mixed Modes of Inheritance Have a Shortage of Recessive Disease. A Demographic Scenario?
7. Factor VIII: the protein, cloning its gene, synthetic factor and now – 35 years later – gene therapy; what happened in between?
8. Complete Inhibition of Acute Humoral Rejection Using Regulated Expression of Membrane-tethered Anticoagulants on Xenograft Endothelium
9. Two novel mutations in severe factor VII deficiency
10. FACTOR VIII – NOVEL INSIGHTS INTO FORM AND FUNCTION
11. Use of a non-depleting anti-CD4 antibody to modulate the immune response to coagulation factors VIII and IX
12. Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins
13. Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM−) and G1948D (CRMr)
14. Efficient Gene Transfer into Human Umbilical Vein Endothelial Cells Allows Functional Analysis of the Human Tissue Factor Gene Promoter
15. Mutation databases on the web
16. Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism
17. Identification of two novel mutations in non-Jewish factor XI deficiency
18. Recent advances in developing specific therapies for haemophilia
19. Advances in Gene Therapy for Hemophilia
20. GO-8: Stable Expression of Factor VIII over 5 Years Following Adeno-Associated Gene Transfer in Subjects with Hemophilia a Using a Novel Human Factor VIII Variant
21. Stable Therapeutic Transgenic FIX Levels for More Than 10 Years in Subjects with Severe Hemophilia B Who Received scAAV2/8-LP1-Hfixco Adeno-Associated Virus Gene Therapy
22. Solution structure of the major factor VIII binding region on von Willebrand factor
23. Solution structure of the major factor VIII binding region on von Willebrand factor
24. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
25. AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage
26. Codon optimization of human factor VIII cDNAs leads to high-level expression
27. Killing 2 birds with 1 stone
28. Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2α mutation
29. Von Willebrand factor multimer patterns in von Willebrand's disease
30. Genotype-phenotype correlation in combined deficiency of factor V and factor VIII
31. Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates
32. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver
33. A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome
34. A common ancestral glycoprotein (GP) 9 1828A>G (Asn45Ser) gene mutation occurring in European families from Australia and Northern Europe with Bernard-Soulier syndrome (BSS)
35. REGULATED INHIBITION OF COAGULATION BY PORCINE ENDOTHELIAL CELLS EXPRESSING P-SELECTIN-TAGGED HIRUDIN AND TISSUE FACTOR PATHWAY INHIBITOR FUSION PROTEINS
36. INHIBITION OF TISSUE FACTOR-DEPENDENT AND -INDEPENDENT COAGULATION BY CELL SURFACE EXPRESSION OF NOVEL ANTICOAGULANT FUSION PROTEINS
37. Expression of Hirudin Fusion Proteins in Mammalian Cells
38. Human Tissue Factor Pathway Inhibitor Fused to CD4 Binds both FXa and TF/FVIIa at the Cell Surface
39. Factor VIII Ise (R2159C) in a Patient with Mild Hemophilia A, an Abnormal Factor VIII with Retention of Function but Modification of C2 Epitopes
40. Inherited Factor VII Deficiency: Molecular Genetics and Pathophysiology
41. Inherited Factor X Deficiency: Molecular Genetics and Pathophysiology
42. Energetic Contributions and Topographical Organization of Ligand Binding Residues of Tissue Factor
43. Inherited Factor VII Deficiency: Genetics and Molecular Pathology
44. Molecular etiology of factor VIII deficiency in hemophilia A
45. Efficient gene transfer into human umbilical vein endothelial cells allows functional analysis of the human tissue factor gene promoter
46. Haemophilia A diagnosis by simultaneous analysis of two variable dinucleotide tandem repeats within the factor VIII gene
47. Synthesis and characterization of wild-type and variant .gamma.-carboxyglutamic acid-containing domains of factor VII
48. Inactivation of factor VIII by factor IXa
49. Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM-) and G1948D (CRMr).
50. Distribution of factor VIII mRNA and antigen in human liver and other tissues.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.